Minimal Residual Disease Testing: Current Innovations and Future Directions

Author:   Todd E. Druley
Publisher:   Springer International Publishing AG
Edition:   1st ed. 2019
ISBN:  

9783319948263


Pages:   197
Publication Date:   27 November 2018
Format:   Paperback
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Our Price $224.37 Quantity:  
Add to Cart

Share |

Minimal Residual Disease Testing: Current Innovations and Future Directions


Add your own review!

Overview

This volume provides a concise yet comprehensive overview of minimal residual disease (MRD) testing. The text reviews the history of MRD testing, MRD testing for acute lymphoblastic leukemia/lymphoma, molecular diagnostics for MRD analysis in hematopoietic malignancies, the use of ""difference from normal"" flow cytometry in monitoring AML response, ML-DS for measurable residual disease detection, and advancements in next generation sequencing for detecting MRD.  Written by experts in the field, Minimal Residual Disease Testing: Current Innovations and Future Directions is a valuable resource for hematologists, oncologists, pathologists, and radiologists on the variety of technologies available to detect MRD and how best to integrate these platforms into clinical practice.

Full Product Details

Author:   Todd E. Druley
Publisher:   Springer International Publishing AG
Imprint:   Springer International Publishing AG
Edition:   1st ed. 2019
Weight:   0.454kg
ISBN:  

9783319948263


ISBN 10:   3319948261
Pages:   197
Publication Date:   27 November 2018
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Active
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Table of Contents

Introduction.- Minimal Residual Disease Testing in Acute Lymphoblastic Leukemia/Lymphoma.- Molecular Diagnostics for Minimal Residual Disease Analysis in Hematopoietic Malignancies.- Monitoring AML Response Using “Difference From Normal” Flow Cytometry.- ML-DS: A Unique Condition for Measurable Residual Disease Detection.- Advancements in Next Generation Sequencing for Detecting Minimal Residual Disease.

Reviews

Author Information

Todd E. Druley, MD, PhDAssociate Professor of Pediatrics, Genetics and Developmental BiologyDirector, Fellowship Program in Pediatric Hematology and OncologyDirector, Pediatric Cancer Predisposition ProgramWashington University in St. LouisDepartment of Pediatrics Division of Hematology and OncologyCenter for Genome Sciences and Systems BiologySt. Louis, MO USA

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

MRG2025CC

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List